Product image of Levetiracetam Sandoz (Levetiracetam) supplied by GNH India

Levetiracetam Sandoz

Active Ingredient:
Levetiracetam
Origin:
EU

Levetiracetam Sandoz (Levetiracetam)

Levetiracetam, the active ingredient in Levetiracetam Sandoz, is an anticonvulsant presented as an injectable solution for intravenous use. It is employed as adjunctive therapy to control partial‑onset, generalized tonic‑clonic and myoclonic seizures in patients with epilepsy, and are typically administered under specialist supervision.

GNH India supplies Levetiracetam Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable quality‑assured batches that meet EU regulatory standards and supporting global procurement teams with responsive logistics and regulatory assistance.

Manufacturer / TM Owner

Sandoz B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Levetiracetam is an antiepileptic drug used as adjunctive therapy for several seizure types.

  • Partial-onset seizures: reduces frequency of focal seizures when added to existing therapy.
  • Generalized tonic-clonic seizures: helps control convulsive seizures in combination with other antiepileptics.
  • Myoclonic seizures: diminishes myoclonic jerks as part of a comprehensive seizure management plan.

How It Works

  • Levetiracetam binds selectively to the synaptic vesicle protein SV2A, a key regulator of neurotransmitter release. This interaction modulates calcium‑dependent exocytosis, stabilizing neuronal firing and decreasing hyper‑excitability in the central nervous system. By reducing the release of excitatory neurotransmitters, the drug helps prevent the initiation and propagation of seizure activity without significant interaction with traditional ion‑channel targets.

Side Effects

Levetiracetam may cause a range of adverse reactions, from mild to severe.

Common Side Effects

  • Dizziness: sensation of light‑headedness or unsteadiness.
  • Somnolence: increased sleepiness or fatigue.
  • Headache: mild to moderate cranial pain.
  • Irritability: mood changes including agitation.
  • Nausea: gastrointestinal discomfort or upset stomach.
  • Fatigue: reduced energy and endurance.

Serious or Rare Side Effects

  • Severe allergic reaction: rash, swelling, or anaphylaxis.
  • Stevens‑Johnson syndrome: serious skin blistering and detachment.
  • Blood dyscrasias: neutropenia, thrombocytopenia, or anemia.
  • Suicidal thoughts: new or worsening depression or suicidal ideation.
  • Severe depression: marked mood disturbances requiring medical attention.
  • Respiratory depression: marked reduction in breathing, especially with concomitant CNS depressants.

Precautions & Warnings

When prescribing Levetiracetam, clinicians should consider several safety and handling factors.

  • Renal impairment: adjust dose based on creatinine clearance.
  • Hepatic function: monitor liver enzymes in patients with liver disease.
  • Pregnancy: safety category unknown; weigh potential benefits against risks.
  • Concomitant CNS depressants: observe for enhanced sedation.
  • Mood changes: monitor for irritability, depression, or suicidal ideation.
  • Store at ambient temperature: keep in original container, protect from moisture and light.

Avoid Interactions

Levetiracetam can interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid)

  • Enzyme‑inducing antiepileptics (e.g., carbamazepine, phenytoin, phenobarbital): may lower levetiracetam plasma levels.
  • Strong CYP inducers (rifampicin, St. John’s wort): reduce drug exposure.
  • Other CNS depressants (opioids, benzodiazepines): increase risk of excessive sedation.

Moderate Interactions (Monitor Closely)

  • Alcohol: may enhance central nervous system depression.
  • Anticoagulants (warfarin): monitor INR as levetiracetam may affect clotting parameters.
  • Other antiepileptics (valproate, lamotrigine): observe for additive side‑effects.
  • Immunosuppressants (cyclosporine): watch for altered drug concentrations.

Frequently Asked Questions

Levetiracetam Sandoz is an injectable antiepileptic indicated as adjunctive therapy for partial‑onset seizures, generalized tonic‑clonic seizures, and myoclonic seizures in patients with epilepsy who require additional seizure control beyond their current regimen.

Levetiracetam binds to the synaptic vesicle protein SV2A, modulating calcium‑dependent neurotransmitter release. This stabilises neuronal firing and reduces hyper‑excitability, thereby decreasing the likelihood of seizure initiation and spread.

The dosage of Levetiracetam Sandoz is determined by the prescribing clinician based on the patient’s age, weight, renal function, and the severity of seizures. No fixed regimen is provided here; dosing must follow the prescriber’s order.

Levetiracetam’s pregnancy category is listed as unknown. Use during pregnancy or lactation should only occur when the potential benefit justifies the potential risk, and the decision must be made by the treating physician after a thorough risk‑benefit assessment.

To place an order, submit an enquiry on the product page at gnhindia.com indicating the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and required import documentation.

Compared with older agents such as valproate or carbamazepine, levetiracetam has a distinct mechanism (SV2A binding) and generally fewer drug‑enzyme interactions, which can simplify combination therapy. However, individual response and tolerability vary, so clinicians choose the agent that best matches the patient’s seizure type and comorbidities.

Store the product at ambient temperature, preferably below 25 °C, in its original packaging. Protect it from moisture, direct sunlight and extreme temperature fluctuations to maintain stability and potency.

Levetiracetam Sandoz is supplied as an injectable solution for intravenous infusion. It is administered by a healthcare professional, typically diluted in compatible IV fluid and infused over a period defined by the prescribing clinician.

Serious risks include severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome, blood dyscrasias, and emergence of suicidal thoughts or severe depression. Patients should be monitored closely for any signs of these conditions, and treatment should be discontinued if they occur.

Levetiracetam is contraindicated in individuals with known hypersensitivity to levetiracetam or any of its excipients. Caution is also advised for patients with severe renal impairment where dose adjustment may be required, and it should be avoided in those where the risk outweighs the benefit as judged by the prescriber.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Levetiracetam

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT